The American Gastroenterological Association, in partnership with Clinical Care Options, LLC, and with support from an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA, invites you to explore the latest in inflammatory bowel disease (IBD) care through the module: “Advancing Inflammatory Bowel Disease Management with Precision Medicine and Emerging Data.”
This educational activity is designed for gastroenterology professionals such as physicians (residents and fellows), nurse practitioners, and physician associates, who are committed to staying at the forefront of IBD treatment.
IBD, encompassing Crohn’s disease and ulcerative colitis, affects more than 2 million in the U.S. and presents ongoing challenges in achieving sustained remission. With the rise of treat-to-target strategies, the focus has shifted toward deep remission, biomarker normalization, and mucosal healing—goals that demand precision and personalization in care.
This module delivers insights into:
- Emerging biomarkers and diagnostics that guide individualized therapy
- Role of biomarkers and treat-to-target approaches in IBD
- Novel targets such as TL1A blockade with antifibrotic potential
Upon completion, learners will be able to:
- Detail available and emerging biomarkers and diagnostics informing treatment decisions in IBD
- Incorporate biomarkers into clinical practice based on guidelines and expert consensus
- Evaluate evidence for the utility of TL1A blockade in IBD treatment
Meet the Faculty:
Jordan E. Axelrad, MD, MPH, FACG
Co-Director, Inflammatory Bowel Disease Center at NYU Langone Health
Associate professor of medicine
NYU Grossman School of Medicine, New York, N.Y.
Dr. Axelrad brings deep clinical expertise and research insight into the evolving IBD landscape, offering learners a practical and evidence-based perspective on precision medicine.
Participants can earn:
0.75 AMA PRA Category 1 Credit™ (Physicians)
0.75 AAPA Category 1 CME credit (Physician Assistants/Associates)
0.75 Nursing contact hour (Nurse Practitioners/Nurses)
For more information, click here.
